The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of veliparib, an oral PARP inhibitor, and M6620 (VX-970), an ATR inhibitor, in combination with cisplatin in patients with refractory solid tumors.
 
Arjun Mittra
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Khanh Tu Do
Consulting or Advisory Role - Jackson Laboratory for Genomic Medicine; Seagen
Research Funding - Lilly (Inst)
 
Sarina Anne Piha-Paul
Research Funding - Abbvie (Inst); Aminex (Inst); Bayer (Inst); BlueLink (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Chugai Pharma (Inst); Curis (Inst); Five Prime Therapeutics (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Helix BioPharma (Inst); Incyte (Inst); Jacobio (Inst); MedImmune (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Puma Biotechnology (Inst); Samumed (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst); TransThera Biosciences (Inst); TransThera Biosciences (Inst); XuanZhu (Inst)
 
Shivaani Kummar
Stock and Other Ownership Interests - Drishti
Consulting or Advisory Role - Corvus Pharmaceuticals; Genentech; MedTree (I); Nodus Therapeutics; Seagen; ShangPharma Innovation
Research Funding - ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Dynavax Technologies (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Pfizer (Inst); Plexxikon (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bayer
 
Naoko Takebe
No Relationships to Disclose
 
Ashley Bruns
No Relationships to Disclose
 
Lamin Juwara
No Relationships to Disclose
 
Lawrence Rubinstein
No Relationships to Disclose
 
Murielle Hogu
No Relationships to Disclose
 
Robert J. Kinders
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; Named inventor on US Patent US8709379 B2
 
Brandon Miller
No Relationships to Disclose
 
Deborah Wilsker
No Relationships to Disclose
 
M. Cecilia Monge B.
No Relationships to Disclose
 
Sabrina Sharmin Khan
No Relationships to Disclose
 
L. Austin Doyle
Patents, Royalties, Other Intellectual Property - I receive royalties for a patent related to cloning and characterizing the ABCG2 transporter. This patent is administered through the University of Maryland School of Medicine. The patent has nothing to do with my current work or any work in ASCO abstrac
 
James H. Doroshow
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose